Dianthus Therapeutics, Inc. /DE/ Quarterly Entity Common Stock, Shares Outstanding from Q2 2018 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2018 to Q3 2024.
  • Dianthus Therapeutics, Inc. /DE/ Entity Common Stock, Shares Outstanding for the quarter ending November 5, 2024 was 29.6M shares, a 99.7% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 29.6M +14.8M +99.7% Nov 5, 2024 10-Q 2024-11-07
Q2 2024 29.4M -31.3M -51.6% Aug 6, 2024 10-Q 2024-08-08
Q1 2024 29.3M -31.3M -51.6% Mar 14, 2024 10-K 2024-03-21
Q3 2023 14.8M -45.7M -75.5% Nov 9, 2023 10-Q 2023-11-09
Q2 2023 60.7M +1.77M +3.01% Jul 31, 2023 10-Q 2023-08-03
Q1 2023 60.6M +1.85M +3.15% Mar 31, 2023 10-K/A 2023-05-01
Q4 2022 60.6M +1.84M +3.13% Jan 31, 2023 10-K 2023-03-23
Q3 2022 60.6M +1.78M +3.03% Oct 31, 2022 10-Q 2022-11-03
Q2 2022 58.9M +323K +0.55% Jul 31, 2022 10-Q 2022-08-04
Q1 2022 58.8M +10.2M +21% Apr 30, 2022 10-Q 2022-05-16
Q4 2021 58.8M +10.2M +21.1% Jan 31, 2022 10-K 2022-03-08
Q3 2021 58.8M +10.5M +21.7% Oct 31, 2021 10-Q 2021-11-04
Q2 2021 58.6M +10.3M +21.4% Jul 31, 2021 10-Q 2021-08-05
Q1 2021 48.6M +9.13M +23.1% Apr 30, 2021 10-Q 2021-05-06
Q4 2020 48.6M +9.23M +23.5% Jan 31, 2021 10-K 2021-03-03
Q3 2020 48.3M +9.32M +23.9% Oct 31, 2020 10-Q 2020-11-05
Q2 2020 48.3M +9.49M +24.5% Jul 31, 2020 10-Q 2020-08-06
Q1 2020 39.5M +5.83M +17.3% Apr 30, 2020 10-Q 2020-05-07
Q4 2019 39.3M Jan 31, 2020 10-K 2020-03-03
Q3 2019 39M +5.84M +17.6% Oct 31, 2019 10-Q 2019-11-13
Q2 2019 38.8M +5.82M +17.7% Jul 31, 2019 10-Q 2019-08-08
Q1 2019 33.7M Apr 30, 2019 10-Q 2019-05-09
Q3 2018 33.2M Oct 31, 2018 10-Q 2018-11-08
Q2 2018 32.9M Jul 31, 2018 10-Q 2018-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.